Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research conducted at Emory University has provided new information about breast cancer
February 1st, 2007
New research, "Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells," is the subject of a report. According to recent research published in the journal Cancer Chemotherapy and Pharmacology, "Phenylacetate (PA) and its derivatives constitute a group of small aromatic fatty acids that have been of considerable interest due to their anticancer properties in a number of experimental systems. We previously showed that PA can inhibit the growth of estrogen receptor (ER)+ breast cancer cells and that this activity is, at least in part, mediated by the ability of the compound to inhibit transcriptional activation driven by estrogen response elements...
Source: Women's Health Weekly (2007-02-01)
|
|
Advertisement |
|
|
|
